1. Home
  2. Azioni
  3. Australia
  4. Australian Stock Exchange
  5. Hexima Limited
  6. Notizie
  7. Altre lingue
    HXL   AU0000111932

HEXIMA LIMITED

(HXL)
  Rapporto
Tempo differito Australian Stock Exchange  -  08:10 27/06/2022
0.0350 AUD   -12.50%
24/06Le azioni australiane sono in rialzo grazie all'aumento dell'IT, in mezzo alla caccia alle occasioni
MT
24/06Hexima condurrà una revisione dettagliata dei dati dello studio di fase 2 sul pezadeftide dopo i risultati 'non conclusivi'; le azioni crollano del 78%.
MT
24/06Hexima Limited annuncia i risultati preliminari dello studio clinico di Fase II di Pezadeftide
CI
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su HEXIMA LIMITED
24/06Australian Shares Jump on IT Boost Amid Bargain Hunting
24/06Hexima to Conduct Detailed Review of Pezadeftide Phase 2 Trial Data after 'Inconclusive..
24/06Hexima Limited Announces Preliminary Results of Phase II Clinical Study of Pezadeftide
29/04HEXIMA: ShareCafe Presentation
28/04HEXIMA: Notification regarding unquoted securities - HXL
05/04HEXIMA: Investor Webinar on Today
24/02HEXIMA: Application for quotation of securities - HXL
24/02HEXIMA: Appendix 4D and Interim Financial Statements
24/02Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2021
08/02HEXIMA: Notification regarding unquoted securities - HXL
01/02HEXIMA: Application for quotation of securities - HXL
30/01HEXIMA: Quarterly Activities Report and Appendix 4C
04/01Hexima Appoints Commercial Chief
03/01Phillip Rose Appoints Phillip Rose as Chief Commercial Officer
2021HEXIMA: Notification regarding unquoted securities - HXL
2021HEXIMA: Notification regarding unquoted securities - HXL
2021Hexima Names New Chief Development Officer
2021HEXIMA: CEO's Presentation
2021Hexima Limited Announces Cessation of Marilyn Anderson as Executive Director
2021Hexima Limited Announces Appointment of Shari Lipner as Member of its Scientific Adviso..
2021Hexima Limited Announces Appointment of Nancy Sacco as Chief Development Officer
2021Hexima Completes Oversubscribed Share Purchase Plan
2021HEXIMA: Application for quotation of securities - HXL
2021Hexima Limited Announces Company Secretary Change
20213,559,437 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending o..
2021Jake Nunn Joins Board of Hexima Limited as Non-Executive Director, effective 1 Septembe..
2021HEXIMA: 2021 Annual Financial Report
2021Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2021
2021Hexima Limited Auditor Raises 'Going Concern' Doubt
2021HEXIMA: Secures Chinese Patent for Fungal Nail Infection Treatment; Shares Surge 12%
2021Hexima Limited Announces Design Patent for Pezadeftide Commercial Packaging
2021Hexima Limited Announces Completion of Enrolment in Phase IIb Clinical Trial
2021HEXIMA: Expects to Secure European Patent for Nail Fungal Infection Treatment
2021Hexima Limited Extends Its Patent Protection for Pezadeftide
2021HEXIMA: Fungal Nail Infection Treatment Receives INN Designation
2021HEXIMA: Secures Patent for Fungal Nail Infection Treatment
2021Hexima Limited to Present Clinical Data from its Phase I/IIa Clinical Trial of HXP 124 ..
2021HEXIMA: R&D Webinar on TodayOpens in a new Window
2021HEXIMA: SAB Formation and R&D Video ConferenceOpens in a new Window
2021HEXIMA: Half Year Report and AccountsOpens in a new Window
2021Hexima Limited Announces Earnings Results for the Six Months Ended 31 December 2020
2021Hexima Limited Updates Timeline to Phase 2B Results
2020Hexima Limited has completed an IPO in the amount of AUD 3.280771 million.
2020Hexima Limited Reports Earnings Results for the Year Ended June 30, 2019
2020Hexima Limited has filed an IPO in the amount of AUD 7.5 million.
2020Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2020
2020Hexima Limited Auditor Raises 'Going Concern' Doubt
2020Hexima Limited announced that it has received AUD 5.5 million in funding
2019Hexima Limited Auditor Raises 'Going Concern' Doubt
2012Hexima Limited Announces Unaudited Consolidated Earnings Results for Six Months Ended D..